OBJECTIVES: Video-assisted thoracoscopic sublobar resection of ultra-small, non-visible and non-palpable pulmonary lesions is challenging. The purpose of this study was to explore an alternative and efficient method for the localization of pulmonary lesions using electromagnetic navigation bronchoscopy (ENB).
INTRODUCTION
Based on GLOBOCAN 2012 estimates, lung cancer is the most common cancer worldwide and the most common cause of cancer-related death [1] . The stage of lung cancer at diagnosis is one of the factors that contributes to a decreased likelihood of survival. High-risk participants who underwent regular computed tomographic (CT) screening in the National Lung Screening Trial had a 20% reduction in the relative risk of death of lung cancer [2] . Due to the increasingly widespread use of CT and the increased resolution of CT imaging, thoracic surgeons are receiving an increasing number of referred patients with small pulmonary nodules. Although most of these nodules may not actually be malignant, biopsy and/or surgical intervention is recommended for some suspicious nodules [3] . Small lesions or those with ground-glass opacity may be difficult to localize because they are not visible, and manual palpation is sometimes needed during the inspection of pulmonary lesions. However, it is almost impossible to accomplish intraoperative palpation, especially in single-port video-assisted thoracoscopic surgery (VATS) and robot-assisted thoracoscopic surgery. Technical improvement is necessary such that small pulmonary nodules can be localized during VATS and robot-assisted thoracoscopic surgery.
Many studies have reported preoperative and intraoperative techniques to localize lung nodules before minimally invasive resection. Current preoperative localization techniques include CT-guided marking with dye [4, 5] , radiotracer labelling [6] and hookwire/microcoil placement [7] [8] [9] [10] . Intraoperative techniques include DynaCT scanning, intraoperative ultrasound and fluorescent thoracoscopic localization in a hybrid operating room (OR) [11] . However, dye diffusion and implant displacement, which mainly occur during patients' transportation to the OR, can lead to localization failure. In addition, the risks of CT-guided transthoracic localization procedures include pleural-related complications, such as pleuritic pain, pneumothorax, haemothorax and air embolus. Simultaneous techniques that require careful coordination among multiple disciplines, complex procedures and specialists with extensive experience can help to minimize the complications that can result from patient transfer and procedural delays.
Electromagnetic navigation bronchoscopy (ENB) involves the conversion of 2D preoperative CT images into a 3D virtual bronchial map, followed by the use of a steerable bronchoscopic instrument with a sensor probe that communicates with an electromagnetic board to generate a field in which the probe's position can be sensed [12] . In theory, dye injection with ENBguided localization could be used to enable better pulmonary nodule localization during VATS. The purpose of this study was to evaluate the feasibility of ENB-guided localization using a new dye formula and minimally invasive resection for ultra-small and non-palpable lesions in lungs.
MATERIALS AND METHODS
We retrospectively report our initial experience with the novel approach of ENB-guided dye marking, followed by VATS resection for definitive diagnosis of pulmonary nodules at the Sun Yat-sen University Cancer Centre from May 2015 to April 2016. The same surgery team (K.L., Y.L., L.Z. and colleagues) performed the ENB, the dye marking and the VATS. The patients included in this study fulfilled the following criteria: (i) the pulmonary nodules were <20 mm in diameter and were located in peripheral parenchyma; (ii) the lesions were resectable and had surgical indications after clinical work-up; and (iii) the patients were medically fit after clinical evaluation [3] . This study was approved by the Ethics Committee of the Sun Yat-sen University Cancer Centre. Informed consent was obtained from all patients before the operation.
Surgical procedure
ENB-guided dye marking was performed by a thoracic surgeon in the OR at the same time as the resection. Using 'superDimension' software (Medtronic, Shanghai, China), the axial, coronal and sagittal views of the patient's CT scan were used to construct a 3D airway tree and plan a navigation pathway to the nodule. General endotracheal anaesthesia was induced in the OR with a singlelumen endotracheal tube. Each nodule was then localized with the navigational console, a locatable electromagnetic guide (LG) and an extended working catheter (EWC; Fig. 1 ). During real-time navigation, the distance between the LG and the nodule could be measured. After the lesion was located, the position of the LG with EWC was adjusted to more than 1.5 cm from the nearest pleural surface to avoid perforation, and the LG was removed from the EWC. A novel dye formula containing methylene blue and the fibrin sealant Fibingluraas [fibrin sealant mixed with methylene blue (FSMB); S.H. RAAS, Shanghai, China], which consists of human fibrinogen and human thrombin, was used for marking. Through the EWC, 2 ml of fibrinogen dissolved in sterile water, 2 ml of thrombin dissolved in calcium chloride and 1 ml of methylene blue were injected sequentially midway into the lesion. The patient's airway was cleared of secretions via the bronchoscope after removal of the EWC.
After localization and dye marking, the single-lumen endotracheal tube was replaced with a double-lumen endotracheal tube. The patient was positioned in full lateral decubitus position with slight flexion of the table at the level of the mid-chest. Two incisions were used in all cases, as which the thoracoscope was placed in the 7th or 8th intercostal space in the midaxillary line, and an anterior utility incision is placed in the 5th intercostal space anteriorly (4-5 cm). Upon inspection within the chest, the blue dye was visualized at a section of the pulmonary segment that was still inflated, because the fibrin sealant had already sealed the airway to the nodule (Fig. 1) . The lesion was resected with endoscopic staplers using a wedge resection (Fig. 1 ). A biopsy specimen was then evaluated by opening the specimen in the OR for pathologic confirmation by frozen-section analysis. If the diagnosis was malignant (not including atypical adenomatous hyperplasia), lobectomy with lymph node dissection was performed. Two independent pathologic teams evaluated the resected specimen. One team was in charge of frozen-section diagnosis, and the other was in charge of the routine institutional protocols (haematoxylin and eosin and immunohistochemical staining, etc.).
Statistical design and analysis
Information on patient demographic characteristics, history, comorbidities, nodule characteristics, operative details, perioperative outcomes and pathologic diagnosis was collected. Continuous variables are presented as medians with range and average. Statistical analyses were carried out using SPSS statistical software for Windows (IBM, SPSS statistics, version 22.0, SPSS, Inc., Chicago, IL, USA).
RESULTS

Patient characteristics
Twenty-four patients with 30 lesions underwent ENB-guided dye marking followed by VATS. Eight men and 16 women were enrolled in the study; their median age was 58 years (range, 44-78 years). Twenty patients (83.3%) had 1 nodule, and 4 patients (16.7%) had 2 or more nodules. Other clinical features are shown in Table 1 .
Characteristics of the pulmonary nodules
The locations of the 30 lesions were variable, with the right lower lobe (36.7%) being the most common site (Table 2) . Eight patients had pure subsolid nodules, and 7 patients had part-solid nodules. The median maximum diameter of the localized nodules was 11.0 mm (range, 6.0-19.0 mm; average, 12.0 ± 7.4 mm). The median maximum distance from the centre of the lesion to the nearest pleural surface was 15.0 mm (range, 1.0-31.0 mm; average, 13.5 ± 9.4 mm; Table 2 ). Three nodules of <8 mm (2 of 6 mm and 1 of 7 mm) were found in 2 patients with multiple lesions. Both patients had another nodule of >8 mm (15 mm and 16 mm), and both were medically fit after clinical evaluation. Both patients had given consent before surgery for resection of all nodules.
Surgical approach and perioperative outcomes
ENB-guided dye marking was successfully performed in all cases. No complications were reported from the ENB-guided localization, except for airway spasms in 1 patient (4.2%). The median navigation time (from registration of airway mapping to injection of FSMB) was 18.0 min (range, 13.0-120.0 min; average, 30.5 ± 25.7 min). The median interval time (from injection of FSMB to inspection by thoracoscopy) was 20.0 min (range, 15.0-40.0 min; average, 21.9 ± 5.8 min). All pulmonary lesions were resected under VATS, and none of the procedures required conversion to thoracotomy. There were no postoperative complications, and the operative mortality rate was 0%. Only 1 patient with bilateral lesions underwent secondary surgery. The other patients with multiple lesions underwent complete resection in the same operation. 
Inspection and pathological evaluation of the pulmonary nodule
In all cases, the index lung nodule was localized and resected with pathological confirmation of the diagnosis. The lesion was inspected during surgery to confirm the appropriate margin of resection and the nodule characteristics before it was sent to pathology. In most procedures, the dye was seen on the pleural surface closest to the tumour. If the pleural tattoo was not observable, the pulmonary subsegment still had a tactile sensation in every case, because the fibrin sealant turned to jelly inside the lung and sealed the airway to the lesion after the injection. In no case the diagnoses from the 2 pathologic teams were contradictory. The blue dye did not interfere with the pathologic assessment even in the frozen-section analysis. However, the pathologic evaluation in frozen-section was only asked to distinguish whether a lesion is benign or malignant. The resected specimens were evaluated by a pathologist, and the resection margins were negative upon both gross and microscopic assessment. A definitive diagnosis was obtained for all patients by pathologic evaluation. In 19 cases (63%), the final pathologic evaluation showed a neoplastic lesion (Table 2) , including 14 patients with invasive adenocarcinoma, 2 patients with adenocarcinoma in situ and 3 patients with atypical adenomatous hyperplasia. The nonneoplastic nodules were granulomatous or inflammatory lesions. The final pathologic diagnosis was consistent with the intraoperative frozen section in all cases. Therefore, there were 16 cases undergoing the lobectomy with lymph node dissection and 8 cases undergoing the wedge resection.
DISCUSSION
In this study, a novel dye formula, FSMB, was used for dye marking. Twenty-four patients with 30 lesions underwent dye marking of pulmonary nodules <20 mm in diameter using ENB guidance and FSMB injection, immediately followed by VATS resection. Pure or partial ground-glass opacity was found in 50% of the patients. A 100% success rate was demonstrated for pulmonary parenchyma staining where the target lesion was located, and all nodules were successfully resected without conversion to thoracotomy. There were almost no complications related to ENBguided dye marking or wedge resection. Navigation time and interval time did not significantly prolong the total operation time. Therefore, this novel technique could be safely and effectively performed in a single setting in an ordinary OR without an increased requirement for rapid preparation before inspection under VATS. A coordinated effort across multiple departments (specifically the OR staff and interventional radiologist) is not necessarily needed. To the best of our knowledge, this is the first published study on ENB-guided marking using a special dye for the VATS resection of small and non-palpable lung nodules.
Several groups have reported some explorative studies about ENB-guided dye marking with methylene blue or indigo carmine [13] [14] [15] [16] [17] . Krimsky and colleagues performed ENB-guided dye marking of pulmonary nodules in 21 patients with either methylene blue (11 patients) or indigo carmine (10 patients), followed by VATS or robot-assisted thoracoscopic surgery resection [14] . They reported that 19% of the nodules targeted were not marked successfully because of diffuse staining of the parietal pleura in 1 patient, and no dye marking could be identified in the other 3 patients. Marino and colleagues also reported a similar phenomenon of lung pleura with extravasated methylene blue all over the surface [17] . The failure rate of transthoracic marking with CT-guided methylene blue injection was also reported as 13% [18] . In our study, the fibrin sealant turned to jelly inside the airway and limited the methylene blue diffusion. After 20 to 30 min, there were no cases with extravasated staining in the visceral and parietal pleura.
Awais and colleagues reported another marking method in which lesions within 1 cm of the pleural surface were directly injected, and in cases in which the lesion was >1 cm from the pleural surface, dye marking was performed midway between the lesion and the nearest pleural surface [16] . The methylene blue spread occurred rarely and did not interfere with localization. However, this method may not be suitable for nodules in the posterior side of the pulmonary parenchyma because the stained pleural surface was not easily observed. It also could not indicate a range of the lesion. In this study, 50% of the patients had pure or partial ground-glass opacity that was not palpable during inspection under VATS. If it is extremely difficult to complete the resection with a safe margin, the surgeon would have to consider conversion to a more aggressive procedure, such as extended wedge resection or lobectomy. However, the pulmonary parenchyma with the target lesion became palpable, because the fibrin sealant turned to jelly and sealed the airway to the lesion after the injection. The resection margin was concurrent with the inflated area of pulmonary parenchyma. Therefore, the important novelty of the new method is the peculiar blocking of the airway, which entraps both air and dye distally.
The ENB-guided dye marking technique was believed to have 2 potential disadvantages when this study began. First, we were concerned about an allergic reaction to fibrin glue. 'Fibingluraas' is a topical haemostasis drug. It is used in the treatment of burns, abdominal incisions in general surgery, oozing of blood in operations and blood vessel surgery. It is absorbed completely after 72 h. Because fibrin sealant does not contain synthetic or bovine aprotinin, it has a reduced potential for hypersensitivity reactions and is widely used in many surgeries [19] . Methylene blue has been proposed as a safe treatment option for refractory anaphylaxis [20] . Airway spasms were seen during the navigation in only 1 case (4.2%), which was not related to the dye injection. Second, we were concerned about whether the dye would affect the pathological evaluation of the resected specimens. Although a previous study had reported that methylene blue did not affect the pathological evaluation of resection specimens [21] , we designed the protocol to adjust the LG with EWC to 1.0-1.5 cm from the nodule before injection to avoid staining in situ. In addition, 2 independent pathologic teams were invited to evaluate the resected specimens. The diagnoses of the 2 pathologic teams were not contradictory. The blue dye did not interfere with the pathologic assessment, even in the frozen-section analysis.
Limitations
Our study is limited by the constraints of a retrospective study and a single surgical team. This approach may have conferred a selection bias. Another difficulty is the lack of a well-matched control group to show the rates of thoracotomy among patients with similar nodules that were not marked before VATS. We did not ascertain whether some of the marked nodules could have been palpated without dye marking during VATS. Besides, there was another limitation in this study. It was not a mandatory requirement that the pathologic evaluation was asked to divide the subtype of malignant lesions. However, it is reported in a large cohort study that at least in 70-80% of intraoperative frozen section it is possible to stratify the malignant lesion into adenocarcinoma in situ, minimal invasive adenocarcinoma and invasive adenocarcinoma [22] . It is valuable that the choice of adequate lung-sparing procedures is based on frozen section. Because this is the initial experience with this novel approach of ENB-guided dye marking, further studies are required to fully evaluate its indication and efficacy.
CONCLUSION
In conclusion, our preliminary result suggests that ENB-guided dye marking using methylene blue mixed with a fibrin sealant is feasible and could be used for accurate intraoperative identification of small and even non-palpable pulmonary nodules. With visible staining and artificial tactile sensations, this technique using the new dye formula appears to be a viable option for diagnosis in patients with suspicious pulmonary nodules that would be difficult to locate thoracoscopically. Further studies are required to identify the patient population that will be best suited for localization and resection with this technique.
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